Mannatech Inc. (MTEX) Stock Price

MTEXStock

$7.13−59.73%52W

Market Cap$13.75M

P/E4.42x

PEG Ratio0.96

Div yield8.83%

Beta0.64

MTEX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-3.40%

Price vs S&P 500 (4W)-11.25%

PEG Ratio0.96

VGM Score54.02

P/E Ratio (Annual)4.42x

Indicated Dividend Yield (Annual)8.83%

P/CF (Annual)4.86x

Book Value / Share (Quarterly)$3.66

P/TBV (Annual)3.01x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)-7.66%

Cash Flow / Share (Quarterly)$0.83

Price vs S&P 500 (YTD)-24.19%

Gross Margin (TTM)76.07%

Net Profit Margin (TTM)-6.90%

EPS (TTM)$-3.91

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-3.91

Revenue Growth (5Y)-6.53%

EPS (Annual)$-8.00

Dividend / Share (Annual)$0.00

ROI (Annual)19.84%

Gross Margin (Annual)74.94%

Net Profit Margin (5Y Avg)-2.16%

Cash / Share (Quarterly)$3.13

Revenue Growth QoQ (YoY)3.78%

EPS Growth (5Y)-0.80%

P/E Normalized (Annual)4.42x

ROA (Last FY)-50.72%

Revenue Growth TTM (YoY)-4.97%

EBITD / Share (TTM)$1.94

ROE (5Y Avg)8.05%

Operating Margin (TTM)2.49%

Cash Flow / Share (Annual)$-2.27

P/B Ratio1.98x

P/B Ratio (Quarterly)2.72x

Net Income / Employee (Annual)$-89,500

EV / Revenue (TTM)0.10x

Net Interest Coverage (TTM)-0.15x

ROA (TTM)-24.43%

EV / EBITDA (TTM)3.04x

EPS Incl Extra (Annual)$-8.00

Current Ratio (Annual)1.10x

Quick Ratio (Quarterly)0.46x

3-Month Avg Trading Volume0.02M

52-Week Price Return-59.73%

EV / Free Cash Flow (Annual)3.82x

Revenue / Employee (TTM)$631,500

Tangible BV / Share (Quarterly)$4.46

P/S Ratio (Annual)0.13x

Asset Turnover (Annual)3.60x

52-Week High$12.45

Operating Margin (5Y Avg)1.09%

EPS Excl Extra (Annual)$-8.00

CapEx CAGR (5Y)7.33%

Tangible BV CAGR (5Y)-20.86%

26-Week Price Return6.50%

Quick Ratio (Annual)0.47x

13-Week Price Return51.27%

Total Debt / Equity (Annual)0.46x

Current Ratio (Quarterly)1.15x

Enterprise Value$11.27M

Revenue / Share Growth (5Y)-2.90%

Asset Turnover (TTM)3.54x

Book Value / Share Growth (5Y)-16.67%

Revenue / Employee (Annual)$635,500

Inventory Turnover (Annual)2.64x

Pretax Margin (Annual)-2.67%

Cash / Share (Annual)$3.25

3-Month Return Std Dev103.23%

Gross Margin (5Y Avg)76.99%

Net Income / Employee (TTM)$-43,600

EBITDA CAGR (5Y)-36.60%

EBITDA Interim CAGR (5Y)-12.13%

ROE (Last FY)28.91%

Net Interest Coverage (Annual)0.22x

EPS Basic Excl Extra (Annual)$-8.00

P/FCF (TTM)4.81x

Receivables Turnover (TTM)393.27x

EV / Free Cash Flow (TTM)7.06x

Total Debt / Equity (Quarterly)0.53x

EPS Incl Extra (TTM)$-3.91

Receivables Turnover (Annual)10803.80x

ROI (TTM)-14.98%

P/S Ratio (TTM)0.13x

Pretax Margin (5Y Avg)0.97%

Revenue / Share (Annual)$56.83

Tangible BV / Share (Annual)$4.46

Free OCF CAGR (5Y)-11.90%

Price vs S&P 500 (52W)-64.43%

Year-to-Date Return-13.64%

5-Day Price Return-8.54%

EPS Normalized (Annual)$-8.00

ROA (5Y Avg)-8.39%

Net Profit Margin (Annual)-14.08%

Month-to-Date Return-0.77%

Cash Flow / Share (TTM)$-2.94

EBITD / Share (Annual)$0.35

EPS Growth (3Y)-34.34%

Operating Margin (Annual)-0.39%

LT Debt / Equity (Annual)0.34x

P/CF (TTM)5.60x

ROI (5Y Avg)6.69%

LT Debt / Equity (Quarterly)0.42x

EPS Basic Excl Extra (TTM)$-3.91

P/TBV (Quarterly)3.01x

P/B Ratio (Annual)2.94x

Dividend / Share (TTM)$0.00

Inventory Turnover (TTM)2.32x

Pretax Margin (TTM)4.66%

Book Value / Share (Annual)$4.57

Price vs S&P 500 (13W)48.59%

Net Margin Growth (5Y)0.19%

Dividend Yield (TTM)0.00%

Beta0.64x

P/FCF (Annual)7.00x

Revenue / Share (TTM)$55.63

ROE (TTM)-22.75%

52-Week Low$3.80

vGradeB

gGradeD

mGradeB

vgmGradeC

MTEX Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2013	May 10, 2013	—	$0.24	—
Q3 2012	Nov 7, 2012	—	$0.83	—

Industry Peers — Pharmaceutical Preparations(21)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
MTEXMannatech Inc.	B	D	B	0.1x	-5.0%	76.1%	-0.8%	$7.13
RGCRegencell Bioscience Holdings Limited Ordinary Shares	—	—	B	—	—	—	—	$9.59
DFTXDefinium Therapeutics, Inc. Common Shares	—	—	B	—	—	—	—	$32.10
TRLVTrulieve Cannabis Corp.	B	C	A	1.7x	-3.9%	59.5%	—	$10.01
CRONCronos Group Inc. Common Share	C	B	A	6.6x	37.5%	46.5%	-50.0%	$3.21
TLRYTilray Brands, Inc. Common Stock	B	B	D	0.5x	15.9%	29.1%	—	$3.04
CGCCanopy Growth Corporation Common Shares	B	C	D	1.6x	6.8%	28.5%	—	$0.71
SNDLSundial Growers Inc. Common Shares	B	C	B	0.5x	-1.7%	26.2%	—	$1.25
GLASGlass House Brands Inc.	B	C	D	1.2x	-25.6%	30.8%	—	$3.19
USNAUSANA Health Sciences Inc	B	D	C	0.3x	5.7%	77.5%	-37.0%	$15.54
ACBAurora Cannabis Inc. Common Shares	B	D	B	1.3x	-18.9%	6.3%	—	$3.99
NAGENiagen Bioscience, Inc. Common Stock	C	C	D	1.5x	11.0%	64.2%	—	$2.49
MDWDMediWound Ltd.	D	F	C	12.9x	-40.3%	15.5%	—	$11.85
FTLFFitLife Brands, Inc. Common Stock	B	C	C	0.8x	17.0%	36.5%	-20.0%	$8.39
BTMDBiote Corp. Class A Common Stock	A	D	D	0.2x	-7.8%	68.6%	-26.8%	$1.08
BONBon Natural Life Limited Class A Ordinary Shares	A	D	C	0.5x	-12.9%	22.1%	—	$1.14
NAIINatural Alternatives International Inc.	A	C	D	0.1x	9.8%	6.3%	—	$1.15
AKANAkanda Corp. Common Shares	C	F	F	12.2x	-63.1%	-60.5%	—	$1.20
IMCCIM Cannabis Corp. Common Shares	A	B	F	0.1x	12.7%	18.6%	—	$1.39
SNYRSynergy CHC Corp. Common Stock	A	C	F	0.0x	8.3%	65.4%	118.4%	$0.03
MEHAFunctional Brands, Inc. Common Stock	A	C	C	0.0x	—	53.7%	—	$0.00
TRUUVanEck Utilities TruSector ETF	—	—	B	—	—	—	—	$23.11

About Mannatech Inc.

Mannatech Inc is a wellness company that develops and sells nutritional supplements, skincare products, and weight-management solutions. The company operates across three major regions—the Americas, Europe/Middle East/Africa, and Asia/Pacific—with the Americas generating the majority of its revenue. Its product portfolio targets consumers seeking health and anti-aging benefits.